Psychedelics
MagicMed möchte Partnern bei der Entwicklung von Psychedelika in Pharmaqualität helfen
Durch die zunehmende Verbreitung von psychischen Erkrankungen und die steigende Akzeptanz von Psychedelika zur Behandlung dieser Krankheiten, rechnet das Data Bridge Market Research Zentrum mit einer durchschnittlichen jährlichen Wachstumsrate in der Psychedelika-Industrie von 16,3% auf 6,85 Mrd. USD. Mit mehr als 15 börsennotierten Unternehmen haben Anleger eine immer mehr Optionen, in diesem Bereich. MagicMed Industries […]
NUMINUS ANNOUNCES SHORT FORM PROSPECTUS OFFERING OF UNITS FOR GROSS PROCEEDS OF UP TO $4.05 MILLION
VANCOUVER, BC, July 22, 2020 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted therapies, is pleased to announce it has entered into an engagement letter with Mackie Research Capital Corporation (the “Agent” or “Mackie“) in […]
GREENSTAR BIOSCIENCES SIGNS DEFINITIVE AGREEMENT TO ACQUIRE 100% OF ELEUSIAN BIOSCIENCES CORP.
ollowing up on our signing of the Letter of Intent, GreenStar and Eleusian have executed a definitive agreement to acquire 100% of Eleusian. Following closing, this will add an innovative company focused on the development of effective therapeutics using psychedelic medicine to the GreenStar portfolio. GreenStar continues its efforts to expand in transformational medicine and Eleusian represents an exciting entry […]
Novamind Announces Closing of Oversubscribed Private Placement
Novamind Ventures Inc. (“Novamind” or the “Company“), a mental health and wellness company specialized in Psychedelic-Assisted Psychotherapy (PAP), is pleased to announce that it has closed an oversubscribed private placement (the “Financing“) raising aggregate gross proceeds of CAN$4.4 million, upsized from an original CAN$3.0 million target. The proceeds of the Financing will support investments in […]
Calgary, Alberta, July 20, 2020 – MagicMed Industries Inc. (“MagicMed” or the “Company“) is pleased to announce that it has engaged Mackie Research Capital Corporation (the “Agent“) to sell, by way of a private placement on a best efforts basis, up to 6,000,000 common shares in the capital of the Company (“Common Shares“) at […]
VANCOUVER, British Columbia, July 16, 2020 (GLOBE NEWSWIRE) — Clarmin Explorations Inc. (TSX.V: CX) (the “Company” or “Clarmin”), a Tier 2 mining issuer listed on the TSX Venture Exchange (the “TSXV”), is pleased to announce the proposed management team and board of directors of the issuer (the “Resulting Issuer”) resulting from the proposed reverse takeover […]
PharmaDrug Inc. Proposes a Strategic Mutual Investment with Red Light Holland Corp.
Toronto, Ontario–(Newsfile Corp. – July 15, 2020) – PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company”) is pleased to announce that it has entered into a share exchange agreement with Red Light Holland Corp. (CSE: TRIP) (“RLH”), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a […]
Pure Extracts Seasoned Team Leading The Way In Mushroom Extraction
The initiative to legalize psilocybin, the compound in “magic mushrooms” responsible for the psychedelic effect, is gaining momentum, offering new hope for sufferers of maladies like PTSD, anxiety and addiction, amongst others. On June 30, Oregon Live reported that over 164,000 signatures have been collected, enough to bring legalizing psilocybin in a therapeutic setting […]
MYDECINE INNOVATIONS GROUP INC. SIGNS DEFINITIVE AGREEMENT FOR ACQUISITION OF NEUROPHARM INC.
DENVER , July 14, 2020 /CNW/ — Mydecine Innovations Group Inc. (MYCO.CN) (MYCOF) (0NF.F) (“Mydecine” or the “Company”), is pleased to announce that, further to its press release on June 10, 2020 , it has entered into a definitive share exchange agreement (the “Share Exchange Agreement”) for the acquisition (the ” Acquisition “) of 100% […]
Beckley Psytech raises £3m to develop ground-breaking psychedelic medicines
Beckley Psytech, the psychedelic medicine company, has raised £3m of Series A funding to develop a pipeline of psychedelic drugs into licensed pharmaceutical medicines for treating psychiatric and neurological diseases. Investors in the round include prominent British businessmen Jim Mellon and Richard Reed, co-founder of Innocent Drinks. The Beckley Psytech team comprises talent from the […]
MagicMed Industries Files First Psychedelic Derivative Patent
Calgary, Alberta, July 9, 2020 – MagicMed Industries Inc. (“MagicMed” or “the Company”) today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) covering composition of matter, drug formulation and process of preparation claims for novel psilocybin derivatives. This patent filing is anticipated to be […]
Hinterland Metals Inc. Signs Letter of Intent with Novamind Ventures Inc.
July 6, 2020 This news release is intended for distribution in Canada only and is not authorized for distribution to United States newswire services or for dissemination in the United States. TORONTO, ON / ACCESSWIRE / July 6, 2020 / Hinterland Metals Inc. (the”Company“or”Hinterland“) is pleased to announce that it has signed a binding letter of […]
OSOYOOS PROVIDES CORPORATE UPDATE ON AI PHARMA ACQUISITION
Toronto, Ontario–(Newsfile Corp. – July 8, 2020) – Osoyoos Cannabis Inc. (CSE: OSO) (“Osoyoos” or the “Company”) today provided a corporate update on its previously announced acquisition of 1196691 B.C. Ltd. d/b/a “PCAI Pharma” (“PCAI“) and its wholly-owned subsidiary AI Pharmaceuticals Jamaica Limited (“AI Pharma“). About PCAI PCAI is a Toronto-based pharmaceutical company with an […]
Havn Life Sciences Inc. Announces Appointment of Gary Leong as Chief Science Officer
Havn Life Sciences Inc. (the “Company” or “Havn Life”), announces the appointment of Gary Leong as Chief Science Officer of Havn Life. Mr. Leong has over thirty (30) years of experience in the Pharmaceutical and Natural Health Products (“NHP”) industry. Mr. Leong was the Chief Scientific Officer at Aphria Inc. in Leamington, ON from its […]
Cybin Corp. (“Cybin” or the “Company”), Canada’s premier mushroom life sciences company focused on advancing psychedelic and nutraceutical-based products derived from fungi, is pleased to announce that it has entered into a feasibility agreement with IntelGenx Corp. (OTCQB:IGXT; TSX-V:IGX) (“IntelGenx”) for the development of an orally-dissolving film for the delivery of pharmaceutical-grade psilocybin, subject to […]
VANCOUVER, British Columbia, July 7, 2020 /CNW/ — Mydecine Innovations Group Inc. (CSE:MYCO.CN – News) (OTC:MYCOF – News) (FSE:0NF.F – News) (“Mydecine” or the “Company”), announced today that seven-time Nobel Prize-nominated scientist Dr. Malireddy Srinivasulu Reddy will be joining the Mydecine team as a Scientific Advisor. Dr. Reddy is one of the world’s most pre-eminent authorities in applied microbiology as it relates to […]
TORONTO, June 30, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has submitted today its Investigational New Drug (“IND”) application to the U.S. Food and Drug […]
June 29, 2020 Vancouver, British Columbia – (June 29, 2020) – North Sur Resources Inc. (“North Sur”) and Mindset Pharma Inc. (“Mindset”) are pleased to announce that they have signed a binding letter of intent (the “Letter of Intent”) to combine their corporate entities. Mindset is an Ontario-based psychedelic pharma company that has filed multiple patents […]
PsyIndex Weekly Update: 6/29 – 7/2
The PsyIndex rose 9.2% last week after a turbulent week prior. At least three privately-held psychedelic companies—Entheon Biomedical, Mindset Pharma and Cybin—announced reverse merger transactions to become publicly-traded. Market Performance PsyIndex Weekly Performance: $97.39 (+9.2%) Top Gainers Revive Therapeutics Ltd. +59.39% (CSE: RVV) (OTC: RVVTF) Empower Clinics Inc. +24.21% (CSE: CBDT) (OTC: EPWCF) […]
Havn Life Sciences Inc. Announces Appointment of Gary Leong as Chief Science Officer
Vancouver, BC – Havn Life Sciences Inc. (the “Company” or “Havn Life”), announces the appointment of Gary Leong as Chief Science Officer of Havn Life. Mr. Leong has over thirty (30) years of experience in the Pharmaceutical and Natural Health Products (“NHP”) industry. Mr. Leong was the Chief Scientific Officer at Aphria Inc. in Leamington, ON from its inception in […]
CannaGlobal, Sansero Life Sciences, and Rise Wellness today announced the creation of CannaGlobal Wellness, a global psychedelics leader focused on psilocybin and other natural compounds to promote emotional, mental, and physical wellness. Leveraging an internationally renowned team with a track record of success, the company will be ideally positioned in the evolving psychedelics industry. Lorne […]
MPV Exploration Inc. (“MPV” or the “Company”) is pleased to announce that it has executed a definitive agreement (the “Definitive Agreement”) with Entheon Biomedical Corp. (“Entheon”), whereby the Company will acquire all of the issued and outstanding shares of Entheon pursuant to a three-cornered amalgamation in accordance with Section 269 of the Business Corporations Act […]
Cybin Corp. (“Cybin”), a mushroom life sciences company focused on psychedelic medicines and nutraceutical products, is pleased to announce that it has entered into an amalgamation agreement dated June 26, 2020 (the “AmalgamationAgreement”) with Clarmin Explorations Inc. (TSX.V: CX) (“Clarmin”) and 2762898 Ontario Inc., a wholly-owned subsidiary of Clarmin. Completion of the transactions contemplated in […]
New program offers psychedelic-assisted psychotherapy that enables ‘frontliners’ and others in high-pressure occupations to “return, reset and relaunch” TORONTO , July 2, 2020 /PRNewswire/ — Field Trip Psychedelics Inc. (“Field Trip” or the “Company“), the company redefining mental health and well-being through its ground-breaking work in psychedelics and psychedelic-enhanced psychotherapy, today announced the launch of Field […]
VANCOUVER, British Columbia, June 30, 2020 /PRNewswire/ — Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) (“Mydecine” or the “Company”), is pleased to announce that it has added world renowned drug discovery expert Dr. Denton Hoyer to its Scientific Advisory Board. Dr. Hoyer has been involved in drug discovery at leading pharmaceutical companies and research institutions for the […]
The PsyIndex fell 10.6% last week after trading was suspended in Champignon Brands Inc. (CSE: SHRM, OTC: SHRMF). Field Trip Health also became the latest private company to reveal plans to go public via a reverse merger following a similar move by Silo Wellness the week prior. Market Performance PsyIndex Weekly Performance: $89.20 (-10.6%) Corporate […]
Pure Extracts Enters Functional Mushroom Space Backstopped by Expertise in Cannabis Extraction
There are only a few times that investors get an opportunity to get in front of an emerging industry. Think about cannabis or electric vehicles in recent times. There can be tremendous upside, but there is generally a steep learning curve because the markets are so nascent and unique that everything is a […]
Havn Life Sciences Inc. Announces Launch & Filing of Preliminary Prospectus
Vancouver, BC – Havn Life Sciences Inc. (the “Company” or “Havn Life”), announces launch and filing of its preliminary prospectus. Havn Life is a biotechnology company on a mission to unlock human performance using evidence-informed research. The Company is aimed at improving cognitive performance through the standardized extraction of psychoactive compounds and the development of natural health […]
3 Ways to Invest in the Nascent Psychedelics Industry
The psychedelics industry is projected to grow from about $2 billion in 2019 to nearly $7 billion by 2027, according to Data Bridge Market Research, representing a 16.3% compound annual growth rate. With ongoing clinical trials and support from the FDA, psychedelics could become a viable treatment option for a wide range of mental […]
What is the Most Vital Part of an Effective Psychedelic Treatment?
Millions of people have had a psychedelic experience at some point in their life and with new FDA approved medicines and regulatory changes millions more will soon be able to as well. However, without support, it can be challenging to understand and integrate these experiences. Psychedelic substances are not magic bullets, they are only […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Next Green Wave is a fully integrated premium seed to shelf craft cannabis producer offering products through its in-house brand portfolio and wholesale flower for other large cannabis manufacturers.
Isodiol produces 99% Pure, Natural, Pharmaceutical Grade CBD. Isodiol and its team of collaborators are a group of companies that together grow, harvest, and process hemp on an industrial scale for the extraction of cannabidiol (CBD) to the highest available purity for worldwide distribution. From the largest source of farmed hemp, to wide-scale extraction and […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
